Study finds significant expression of the Alzheimer's related Tau protein in glioma cells, especially in patients with better prognoses.
Researchers consider whether targeting neurons could be an effective way to treat a variety of cancers.
Researchers report they might have discovered why some people are resistant to standard treatments for brain cancer, and it's in their DNA.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
Several variants of the PIK3CA gene drive brain tumor progression. Two of the variants alter the expression of genes involved in synapses.
A newly discovered weakness in brain tumor cells could provide a new target for treating glioblastoma, researchers report.
A new probe developed uses an innovative fluorescence-reading technology to help brain surgeons distinguish cancerous tissue from normal tissue. The probe tool, now already in use at the Cancer Center for brain surgery, may one day be used for surgeries for a variety of cancers.
Researchers believe their findings could lead to new targets for brain cancer therapies.
Researchers use PET neuroimaging technology to help determine which children with DIPG brain cancer will benefit best from Avastin.
A new study reports glioblastoma influences microglia, causing them to stimulate tumor growth, rather than suppress it.
A new zebrafish model holds the potential for future studies of glioblastoma, an aggressive and lethal brain cancer.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
